Abstract:Finding the right balance of quality and quantity can be important, and it is essential that project quality does not drop below the level where important main conclusions are missed or misstated. We use knock-out and over-expression studies as a simplification to test recovery of a known causal gene in RNA-Seq cell line experiments. When single-end RNA-Seq reads are aligned with STAR and quantified with htseq-count, we found potential value in testing the use of the Generalized Linear Model (GLM) implementation of edgeR with robust dispersion estimation more frequently for either single-variate or multi-variate 2-group comparisons (with the possibility of defining criteria less stringent than |fold-change| > 1.5 and FDR < 0.05). When considering a limited number of patient sample comparisons with larger sample size, there might be some decreased variability between methods (except for DESeq1). However, at the same time, the ranking of the gene identified using immunohistochemistry (for ER/PR/HER2 in breast cancer samples from The Cancer Genome Atlas) showed as possible shift in performance compared to the cell line comparisons, potentially highlighting utility for standard statistical tests and/or limma-based analysis with larger sample sizes. If this continues to be true in additional studies and comparisons, then that could be consistent with the possibility that it may be important to allocate time for potential methods troubleshooting for genomics projects. Analysis of public data presented in this study does not consider all experimental designs, and presentation of downstream analysis is limited. So, any estimate from this simplification would be an underestimation of the true need for some methods testing for every project. Additionally, this set of independent cell line experiments has a limitation in being able to determine the frequency of missing a highly important gene if the problem is rare (such as 10% or lower). For example, if there was an assumption that only one method can be tested for “initial” analysis, then it is not completely clear to the extent that using edgeR-robust might perform better than DESeq2 in the cell line experiments. Importantly, we do not wish to cause undue concern, and we believe that it should often be possible to define a gene expression differential expression workflow that is suitable for some purposes for many samples. Nevertheless, at the same time, we provide a variety of measures that we believe emphasize the need to critically assess every individual project and maximize confidence in published results.

Evaluating Reproducibility of Differential Expression Genes Based on Protein-Protein Interactions

Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation

Approaches and Practical Considerations for the Analysis of Toxicogenomics Data

The Reproducibility of Lists of Differentially Expressed Genes in Microarray Studies

The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies

Selecting Reliable Mrna Expression Measurements Across Platforms Improves Downstream Analysis

A two-step strategy for detecting differential gene expression in cDNA microarray data

High heterogeneity undermines generalization of differential expression results in RNA-Seq analysis

Novel Statistical Framework to Identify Differentially Expressed Genes Allowing Transcriptomic Background Differences

Critical Differential Expression Assessment for Individual Bulk RNA-Seq Projects

An Approach to Evaluate the Reliability of Hybridization-Based and Sequencing-Based Gene Expression Profiling Technologies

A New Approach To Identify Differentially Expressed Genes By Integrating Cancer Microarray And Sage Data

Experimental validation of methods for differential gene expression analysis and sample pooling in RNA-seq

Identifying differentially expressed genes in human acute leukemia and mouse brain microarray datasets utilizing QTModel

Evaluation of cDNA microarray data by multiple clones mapping to the same transcript.

A Robust Statistical Procedure to Discover Expression Biomarkers Using Microarray Genomic Expression Data.

Microarray Platform Consistency is Revealed by Biologically Functional Analysis of Gene Expression Profiles

Detecting Differentially Expressed Genes by Relative Entropy.

New Statistics for Testing Differential Expression of Pathways from Microarray Data

A statistical network pre-processing method to improve relevance and significance of gene lists in microarray gene expression studies

A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments